Invention Grant
- Patent Title: Modified alginates for cell encapsulation and cell therapy
-
Application No.: US15208192Application Date: 2016-07-12
-
Publication No.: US10285949B2Publication Date: 2019-05-14
- Inventor: Arturo J. Vegas , Minglin Ma , Kaitlin M. Bratlie , Daniel G. Anderson , Robert S. Langer
- Applicant: Massachusetts Institute of Technology , THE CHILDREN'S MEDICAL CENTER CORPORATION
- Applicant Address: US MA Cambridge US MA Boston
- Assignee: Massachusetts Institute of Technology,The Chidren's Medical Center Corporation
- Current Assignee: Massachusetts Institute of Technology,The Chidren's Medical Center Corporation
- Current Assignee Address: US MA Cambridge US MA Boston
- Agency: Pabst Patent Group LLP
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61K9/50 ; A61K9/51 ; A61K35/39 ; A61K45/06 ; C08B37/00
Abstract:
Covalently modified alginate polymers, possessing enhanced biocompatibility and tailored physiochemical properties, as well as methods of making and use thereof, are disclosed herein. The covalently modified alginates are useful as a matrix for the encapsulation and transplantation of cells. Also disclosed are high throughput methods for the characterizing the biocompatibility and physiochemical properties of modified alginate polymers.
Public/Granted literature
- US20160324793A1 MODIFIED ALGINATES FOR CELL ENCAPSULATION AND CELL THERAPY Public/Granted day:2016-11-10
Information query
